Skip to content

PP&E (Net) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$23.27B+11.5%
Merck & Co. logo
Merck & Co.MRK
$25.43B+2.6%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$112.79M-16.6%
UroGen Pharma logo
UroGen PharmaURGN
$616K-1.8%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$8.63M-2.7%
CG Oncology logo
CG OncologyCGON
$15.07M+5,610%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s PP&E (net)?
Aura Biosciences, Inc. (AURA) reported PP&E (net) of $2.47M in Q1 2026.
How has Aura Biosciences, Inc.'s PP&E (net) changed year-over-year?
Aura Biosciences, Inc.'s PP&E (net) decreased by 20.5% year-over-year, from $3.11M to $2.47M.
What is the long-term trend for Aura Biosciences, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s PP&E (net) has grown at a -6.0% compound annual growth rate (CAGR), from $3.57M to $2.62M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.